Canabinoides no câncer de mama e resultados de longo prazo do estudo APT

Notas do episódio

Referências: Bimonte S, Palma G, Cascella M, Cuomo A. Phytocannabinoids in Triple Negative Breast Cancer Treatment: Current Knowledge and Future Insights. Anticancer Res. 2023 Mar;43(3):993-1000. doi: 10.21873/anticanres.16243. PMID: 36854495. https://ar.iiarjournals.org/content/43/3/993 Sara M Tolaney, MD; Paolo Tarantino, MD; Noah Graham, MB; Nabihah Tayob, PhD; Laia Parè, PhD; Guillermo Villacampa et al. Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial. Published: March, 2023 DOI: https://doi.org/10.1016/S1470-2045(23)00051-7 ou https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00051-7/fulltext --